Total Urinary Arsenic Research Articles

Urinary transforming growth factor-alpha in individuals exposed to arsenic in drinking water in Bangladesh

Recent evidence suggests that the development of skin lesions from arsenic exposure may be mediated by increases in the expression of various growth factors, including transforming growth factor-alpha (TGFα). To investigate this association in humans, levels of total urinary arsenic and urinary TGFα were determined in 41 individuals with and without arsenic-associated skin lesions from Bangladesh who have chronic exposure to arsenic in their drinking water. After adjusting for age and sex, total urinary arsenic was found to be correlated with urinary TGFα (R 2 = 0.37; p < 0.0001), particularly in those individuals with arsenic-associated skin lesions (R 2 = 0.70; p < 0.0001). Stratification of the cohort into quartiles based on urinary TGFα levels demonstrated a trend of increasing odds ratios for the presence of arsenic-associated skin lesions with increasing urinary TGFα, although this was not significant (p = 0.15). These results suggest that urinary TGFα may be a useful biomarker for the epidermal effects of arsenic exposure.

Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh.

The present study examined the associations between drinking water and urinary arsenic levels and skin lesions among 167 residents of three contiguous villages in Bangladesh. Thirty-six (21.6%) had skin lesions (melanosis, hyperkeratosis, or both), of which 13 (36.1%) occurred in subjects who were currently drinking water containing concentrations of arsenic < 50 micrograms/L. The risk for skin lesions in relation to the exposure estimates based on urinary arsenic was elevated more than 3-fold, with the odds ratios for the highest versus the lowest quartiles being 3.6 (95% confidence interval, 1.2 to 12.1) for urinary total arsenic and 3.2 (95% confidence interval, 1.1 to 10.0) for urinary creatinine-adjusted total arsenic. The risks for skin lesions in relation to the exposure estimates based on arsenic in drinking water were less strongly elevated, with the odds ratios for the highest versus the lowest quartiles of exposure being 1.7 (95% confidence interval, 0.6 to 5.1) for drinking-water arsenic and 2.3 for cumulative arsenic index. The study suggests that arsenic exposure is associated with skin lesions in the Bangladesh population and that urinary arsenic may be a stronger predictor of skin lesions than arsenic in drinking water in this population.

Flow Injection Hydride Generation Atomic Absorption Spectrometry for Determination of Arsenic in Water and Biological Samples from Arsenic-Affected Districts of West Bengal, India, and Bangladesh

The increasing concern over human exposure to arsenic in West Bengal and Bangladesh has necessitated the development of a rapid method for determination of trace levels of arsenic in water and biological samples. We have developed a simple indigenous flow injection hydride generation atomic absorption spectrometry (FI-HG-AAS) system for the determination of arsenic in parts-per-billion levels in water and biological samples. The technique is fast, simple, and highly sensitive. The accuracy and precision of the method were evaluated by spiking known amounts of arsenic and analyzing different types of environmental and biological standard reference materials. The organic matter in a biological sample was destroyed by acid digestion and dry ashing technique. We analyzed thousands of tubewell water samples from the affected districts of West Bengal and Bangladesh. Most of the water samples contained a mixture of arsenite and arsenate and in none of them could we detect methylated arsenic. We also analyzed thousands of urine (inorganic arsenic and its metabolites), hair, and nail samples and hundreds of skin-scale and blood samples of people drinking arsenic-contaminated water and showing arsenical skin lesions. Quality control was assessed by interlaboratory analysis of hair samples. An understanding of arsenic toxicity and metabolism requires quantitation of individual arsenic species. The techniques we used for the determination and speciation of arsenic are (i) separation of arsenite and arsenate from water by sodium diethyldithiocarbamate in chloroform followed by FI-HG-AAS; (ii) determination of arsenite in citrate/citric buffer at pH 3 and total arsenic in water in 5 M HCl by FI-HG-AAS. Thus, arsenate is obtained from the difference; (iii) for analysis of inorganic arsenic and its metabolites in urine FI-HG-AAS was used after separation of the species with a combined cation-anion exchange column. Total arsenic in urine was also determined by FI-HG-AAS after acid decomposition. The species arsenite and arsenate are present in groundwater in about a 1:1 ratio and about 90% of the total arsenic in urine is present as inorganic arsenic and its metabolites.

Determination of arsenic species in human urine using HPLC with on-line photooxidation or microwave-assisted oxidation combined with flow-injection HG-AAS

An improved analytical procedure is presented for the separation and simultaneous determination of hydride-forming (toxic) and not hydride-forming (non-toxic) arsenic species in human urine. Separation was performed by cation-exchange chromatography using a new solid phase type based on the continuous bed chromatography (CBC) technology. This column permits by a factor of 4 higher flow rates than conventional columns resulting in a drastical reduction of retention times without any loss of resolution. Using this type of column, arsenobetaine (AsBet), arsenocholine (AsChol), and dimethylarsinic acid (DMA) were separated from the more toxic arsenic species arsenous acid (As(III)), arsenic acid (As(V)), and methylarsonic acid (MA) within only 4 min. The HPLC system was coupled via a flow injection system and either a UV or a microwave (MW) reactor to the HG-AAS instrument. UV photolysis and MW digestion were used to transform AsBet and AsChol to hydride-forming species and to make them accessible to HG-AAS. UV photolysis turned out to be more suitable for this application than MW digestion, because the latter technique led to peak broadening and poorer performance. The described procedure was applied to the determination of arsenic species in urine samples of non-occupationally exposed persons before and 12 h after seafood consumption. Detection limits were about 1 μg/L for each arsenic species. After consumption, the AsBet and DMA excretion increased by at least a factor of 150 for AsBet and by a factor of 6 for DMA, respectively, while the excretion of the other species did not increase significantly. This invalidates the use of total urinary arsenic as well as total hydride-forming arsenic as an indicator for exposure to inorganic arsenic.

Alteration in bilirubin excretion in individuals chronically exposed to arsenic in Mexico

We have studied hepatic function in individuals chronically exposed to arsenic (As) via drinking water in Region Lagunera, Mexico. We studied 51 individuals living in three villages exposed to As in water. Nazareno (0.014 mgAs/l), Santa Ana (0.1 mgAs/l) and Benito Juárez (0.3 mgAs/l). We determined the serum activity of aspartate aminotransferase (SAT) and alanine aminotransferase (ALT) as indicators of hepatocellular injury and that of gamma-glutamyl-transpeptidase (GGT) and alkaline phosphatase (ALP) as indicators of cholestasic injury. Serum bilirubin was used as an indicator of organic conjugated anion transport. Total proteins, albumin and globulin fraction in serum were used as indicators of biosynthetic liver capacity. The main findings of this study were the predominantly conjugated hyperbilirubinemia and increased serum ALP activity which were related to the concentration of total arsenic (TAs) in urine, suggesting the presence of cholestasis in As-exposed individuals. No significant changes were observed in the other parameters studied.

Urinary excretion of arsenic species after exposure to arsenic present in drinking water.

The water from some drilled wells in southwest Finland contains high arsenic concentrations (min-max: 17-980 microg/L). We analyzed inorganic arsenic (As-i) and organic arsenic (monomethylarsonate [MMA] and dimethylarsinate [DMA]) species in urine and conducted a clinical examination of current users (n = 35) and ex-users (n = 12) of such wells. Ex-users had ceased to use the water from the wells 2-4 months previously. Urinary arsenic species were also analyzed from persons whose drinking water contained less than 1 microg/L of arsenic (controls, n = 9). The geometric means of the concentrations of total arsenic in urine were 58 microg/L for current users, 17 microg/L for ex-users, and 5 microg/L for controls. The excreted arsenic was associated with the calculated arsenic doses, and on average 63% of the ingested arsenic dose was excreted in urine. The ratios of MMA/DMA and As-i/As-tot (As-tot = As-i + MMA + DMA) in urine tended to be lower among the current users and in the higher exposure levels than in controls, suggesting that As-i was better methylated in current users. However, the differences were mainly explained by age; older persons were better methylators of inorganic arsenic than younger individuals. The arsenic content of hair correlated well with the past and chronic arsenic exposure; an increase of 10 microg/L in the arsenic concentration of the drinking water or an increase of 10-20 microg/day of the arsenic exposure corresponded to a 0.1 mg/kg increase in hair arsenic. The individuals were interviewed and complained of muscle cramps, mainly in the legs, and this was associated with elevated arsenic exposure. The present study demonstrates that arsenic methylation has no threshold at these exposure levels.

Site-specific data confirm arsenic exposure predicted by the U.S. Environmental Protection Agency.

The EPA uses an exposure assessment model to estimate daily intake to chemicals of potential concern. At the Anaconda Superfund site in Montana, the EPA exposure assessment model was used to predict total and speciated urinary arsenic concentrations. Predicted concentrations were then compared to concentrations measured in children living near the site. When site-specific information on concentrations of arsenic in soil, interior dust, and diet, site-specific ingestion rates, and arsenic absorption rates were used, measured and predicted urinary arsenic concentrations were in reasonable agreement. The central tendency exposure assessment model successfully described the measured urinary arsenic concentration for the majority of children at the site. The reasonable maximum exposure assessment model successfully identified the uppermost exposed population. While the agreement between measured and predicted urinary arsenic is good, it is not exact. The variables that were identified which influenced agreement included soil and dust sample collection methodology, daily urinary volume, soil ingestion rate, and the ability to define the exposure unit. The concentration of arsenic in food affected agreement between measured and predicted total urinary arsenic, but was not considered when comparing measured and predicted speciated urinary arsenic. Speciated urinary arsenic is the recommended biomarker for recent inorganic arsenic exposure. By using site-specific data in the exposure assessment model, predicted risks from exposure to arsenic were less than predicted risks would have been if the EPA's default values had been used in the exposure assessment model. This difference resulted in reduced magnitude and cost of remediation while still protecting human health.

Determination of total arsenic in urine by hydride AAS after UV-digestion

A method for analysing arsenic in urine samples by Flow Injection Analysis-Atomic Absorption Spectrometry (FIA-AAS) after ultra-violet (UV) digestion is developed and validated. The validated method has the following performance characteristics: limit of detection (LOD) 0.5 μg L–1, repeatability and reproducibility better than 5% and 10% relative standard deviation (RSD) respectively for arsenic concentrations above 3 μg L–1, linear range 0.5–40 μg L–1. Validation of the method was performed by analysing several certified reference materials. Results obtained were well within the certified intervals. Several urine samples analysed by UV-FIA-AAS were also analysed by Inductively Coupled Plasma-Mass Spectrometry after High Performance Liquid Chromatography (HPLC-ICP-MS) in order to investigate comparability. Again results were satisfactory, arsenic concentrations in urine samples did not differ from each other significantly. Storage conditions were also studied. Urine samples are best stored in polyethylene containers at 5 ± 4°C and are stable in arsenic content for at least 30 days.

INFLUENCE OF DIETARY SELENIUM ON THE DISPOSITION OF ARSENATE IN THE FEMALE B6C3F MOUSE 1

Interactions between arsenic (As) and selenium (Se) at the metabolic level are multifaceted and complex. These interactions are of practical significance because populations in various parts of the world are simultaneously exposed to inorganic As in drinking water and Se mainly in the diet at varying levels. The primary goal of this study was to investigate whether differing dietary Se status would alter the profile of urinary metabolites or their time course for elimination after exposure to arsenate [As(V)]. Weanling female 86C3F, mice were maintained for 28 d on either a control diet of powdered rodent meal sufficient in Se (A 0.2 ppm) or Torula yeast-based (TYB) diets deficient (B, 0.02 ppm Se), sufficient (C, 0.2 ppm Se), or excessive (D, 2.0 ppm Se) in Se; mice then received by oral gavage 5 mg (As)/kg as sodium [{sup 73}As] arsenate. The time course for elimination of total arsenic and metabolites in urine was measured over a 48-h period, and total arsenic was determined in feces and tissues at 48 h. Mice on the Se excess diet excreted a significantly higher percentage of urinary As as inorganic As, with a significantly decreased ratio of organic to inorganic As compared to Se-sufficientmore » mice, suggesting that As methylation was decreased. Mice on the Se-deficient diet appeared to eliminate As(V), arsenite, and dimethylarsinic acid (DMA) in urine more slowly than Se-sufficient mice; however, further studies are required to confirm this finding. Mice on the Se-sufficient meal diet (A) excreted significantly less (by percent) arsenate-derived radioactivity in urine and more in feces compared to mice on the Se-sufficient TYB diet (C), with total elimination being similar for both groups. This indicates that mice on the meal diet absorbed significantly less As(V) than mice on the TYB diet, and this may be due to more fiber or {open_quotes}bulk{close_quotes} in the meal diet. 35 refs., 6 figs., 6 tabs.« less

INFLUENCE OF DIETARY SELENIUM ON THE DISPOSITION OF ARSENATE IN THE FEMALE B6C3F1, MOUSE

Interactions between arsenic (As) and selenium (Se) at the metabolic level are multi-faceted and complex. These interactions are of practical significance because populations in various parts of the world are simultaneously exposed to inorganic As in drinking water and Se mainly in the diet at varying levels. The primary goal of this study was to investi gate whether differing dietary Se status would alter the profile of urinary metabolites or their time course for elimination after exposure to arsenate [As(V)]. Weanling female B6C3F, mice were maintained for 28 d on either a control diet of powdered rodent meal sufficient in Se (A, 0.2 ppm) or Torula yeast-based (TYB) diets deficient (B, 0.02 ppm Se), sufficient (C, 0.2 ppm Se), or excessive (D, 2.0 ppm Se) in Se; mice then received by oral gavage 5 mg (As)/kg as sodium [73As] arsenate. The time course for elimination of total arsenic and metabolites in urine was measured over a 48-h period, and total arsenic was determined in feces and tissues at 48 h. Mice on the Se excess diet excreted a signifi cantly higher percentage of urinary As as inorganic As, with a significantly decreased ratio of organic to inorganic As compared to Se-sufficient mice, suggesting that As methylation was decreased. Mice on the Se-deficient diet appeared to eliminate As(V), arsenite, and dimethylarsinic acid (DMA) in urine more slowly than Se-sufficient mice; however, further studies are required to confirm this finding. Mice on the Se-sufficient meal diet (A) excreted significantly less (by percent) arsenate-derived radioactivity in urine and more in feces compared to mice on the Se-sufficient TYB diet (C), with total elimination being similar for both groups. This indicates that mice on the meal diet absorbed significantly less As(V) than mice on the TYB diet, and this may be due to more fiber or “bulk” in the meal diet.

Determination of toxic and non-toxic arsenic species in urine by microwave assisted mineralization and hydride generation atomic absorption spectrometry

Flow injection — microwave oven — hydride generation — atomic absorption spectroscopy (FI-MO-HG-AAS) has been optimized for the determination of the total and toxic arsenic in urine with and without persulfate, respectively. With microwave oven assisted digestion of urine with 5% (w/v) K2S2O8 and 5% (w/v) NaOH all arsenicals completely can be converted to arsenate, which is determined by HG-AAS to give the total concentration of the six species present in urine. The detection limits of 4–6 μg l–1, the relative standard deviation of 3–7% and the high sample throughput make the methods suitable for rapid routine on-line determination. Application of the proposed procedures to the analysis of urine from people on a diet rich in seafood revealed a significant increase in total urinary arsenic due to the rapid excretion of organoarsenicals. Efficient decomposition and quantitative recovery of all arsenic species in spiked urine is achieved by using 5% K2S2O8 in 5% NaOH at 4.6 ml min−1, microwave power of 700 W and a 1.5 m coil.

Arsenic in ground water in six districts of West Bengal, India: the biggest arsenic calamity in the world. Part I. Arsenic species in drinking water and urine of the affected people

Arsenic in ground water has been found above the maximum permissible limit in six districts of West Bengal covering an area of 34 000 km2 with a population of 30 million. At present 37 blocks of these six districts by the side of the River Ganga are affected and about 800 000 people from 312 villages/wards are drinking arsenic contaminated water and amongst them at least 175 000 people are showing arsenical skin lesions. The source of arsenic is geological. We have analysed thousands of tube-well water samples from these six districts for four arsenic species namely, arsenite, arsenate, monomethylarsonic acid (MMAA) and dimethylarsinic acid (DMAA). We could detect no MMAA or DMAA in any of these samples. In urine, DMAA and MMAA are the predominant species along with arsenite and arsenate. The techniques we used for the determination and speciation of arsenic are: (i) separation of arsenite and arsenate from water by sodium diethyldithiocarbamate in chloroform followed by FI-HGAAS; (ii) spectrophotometry using Ag–DDTC in chloroform with hexamethylenetetramine as absorbing solution; (iii) ion-exchange separation of arsenite and arsenate from water followed by FI-HGAAS; and (iv) for analysis of inorganic arsenic and its metabolites in urine, FI-HGAAS was used after separation of the species by a combined cation–anion-exchange column. Total arsenic in urine was determined by FI-HGAAS after acid decomposition. The most toxic species, arsenite, is present in ground water at about 50% of the total arsenic level, and more than 90% of the total arsenic in urine is inorganic arsenic and its metabolites.

Determination and Speciation of Arsenic in Human Urine by Ion-Exchange Chromatography/Flow Injection Analysis with Hydride Generation/Atomic Absorption Spectroscopy

A flow injection-hydride generation/atomic absorption spectroscopic method for the measurement of total urinary arsenic and for the selective determination of inorganic arsenic, monomethylarsonic acid (MMAA), and dimethylarsinic acid (DMAA) was developed. Destruction of the organic matrix is necessary to measure total arsenic content of urine samples. Digestion of this matrix with HNO3-H2SO4-H2O2 is described. The separation of inorganic, monomethylated, and dimethylated arsenic compounds in urine was performed with ion-exchange chromatography on AG 50 W-X8 resin. Detection limits of 2 ppb for each arsenic form and of 3 ppb for total arsenic in urine analyzed after mineralization were found. Recoveries in triplicate urine samples spiked with 10 ppb inorganic arsenic, 20 ppb MMAA, and 40 ppb DMAA were 93, 91, and 85%, respectively. The precision (relative standard deviation) of the method obtained in 10 replicate analyses of urine samples spiked with arsenic metabolites varied from 3.2 to 4.6%. This method is applicable to urine samples in studies relating to arsenic exposure and its monitoring.

Determination of urinary arsenic and impact of dietary arsenic intake

An analytical method based on microwave decomposition and flow injection analysis (FIA) coupled to hydride generation atomic absorption spectrometry (HGAAS) is described. This is used to differentiate arsenite [As(III)], arsenate [As(V)], monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA) from organoarsenic compounds usually present in seafood. Without microwave digestion, direct analysis of urine by HGAAS gives the total concentration of As(III), As(V), MMA and DMA because organoarsenic compounds such as arsenobetaine, usually found in most seafood, are not reducible upon treatment with borohydride and therefore cannot be determined by using the hydride generation technique. The microwave oven digestion procedure with potassium persulfate and sodium hydroxide as decomposition reagents completely decomposes all arsenicals to arsenate and this can be measured by HGASS. Microwave decomposition parameters were studied to achieve efficient decomposition and quantitative recovery of arsenobetaine spiked into urine samples. The method is applied to the determination of urinary arsenic and is useful for the assessment of occupational exposure to arsenic without intereference from excess organoarsenicals due to the consumption of seafood. Analysis of urine samples collected from an individual who ingested some seafood revealed that organoarsenicals were rapidly excreted in urine. After the ingestion of a 500-g crab, a 10-fold increase of total urinary arsenic was observed, due to the excretion of organoarsenicals. The maximum arsenic concentration was found in the urine samples collected approximately between 4 to 17 hr after eating seafood. However, the ingestion of organoarsenic-containing seafoods such as crab, shrimp and salmon showed no effect on the urinary excretion of inorganic arsenic, MMA and DMA.

Total arsenic in urine: palladium-persulfate vs nickel as a matrix modifier for graphite furnace atomic absorption spectrophotometry

We evaluated the effectiveness of nickel and palladium with or without added potassium persulfate as matrix modifiers for the determination of total arsenic in urine. Complete recovery of pure aqueous solutions of As(III), As(V), cacodylic acid (DMA), monomethylarsinic acid (MMA), and o-arsanilic acid was attained by using both nickel and palladium modifiers. Combined arsenobetaine and arsenocholine (so-called fish arsenic), extracted from a certified control material of dogfish muscle (DORM-1), were completely recovered with Pd-S2O8 matrix modification, but not with nickel. Excellent agreement with target values for arsenic in urines from the Centre de Toxicologie du Quebec, supplied by the Interlaboratory Comparison Program, was attained irrespective of the arsenic source when we used Pd-S2O8 as the matrix modifier.

A Pilot Study on the Urinary Excretion of Porphyrins in Human Populations Chronically Exposed to Arsenic in Mexico

1 The aim of this pilot study was to investigate if the porphyrinuria produced by arsenic in rodents was present in humans chronically exposed to arsenic via drinking water. 2 The concentrations of uroporphyrin, coproporphyrin and total arsenic in urine were compared between 21 individuals exposed to arsenic in their drinking water (0.390 mg l-1) and 19 controls exposed to 0.012 mg l-1. 3 Arsenic-exposed individuals had significantly higher total arsenic concentrations in their urine than the control group. No increase in urinary porphyrin excretion was found in exposed individuals. However, an inversion of the coproporphyrin/uroporphyrin (COPRO/URO) ratio was observed in most exposed individuals. This inversion was caused both, by a decrease in coproporphyrin excretion and an increase in uroporphyrin excretion. 4 No demonstrable correlations between porphyrin excretion, the COPRO/URO ratio and total arsenic concentration in urine were found in exposed individuals.

Quantitation of arsenic species in urine for exposure assessment studies

Accuracy in trace level clinical or biomedical analyses is of increasing importance as populationbased surveillance is more widely used to address issues of nutritional requirements, environmental exposures, and epidemiological outcomes. Among the uses of such surveillance, evaluation of community exposures from a local arsenic pollution source is one example. Urinary biological monitoring is a desirable tool used in conjunction with measurement of environmental levels of arsenic in order to permit assessment of total exposures and to provide a basis for consideration of the relative importance of different routes of exposure and of age-related behaviors in influencing exposure. Urinary arsenic concentrations are indicative of recent (previous 1-2 days) exposures to arsenic. When total urinary arsenic is measured, total arsenic intake is assessed. When exposures to inorganic arsenic (in the forms of oxides or salts of trivalent or pentavalent arsenic) are of interest, determination of urinary arsenic species comprising the major metabolites of inorganic arsenic exposures is most appropriate [1]. A recent two-year study of community exposures to environmental inorganic arsenic pollution utilized urinary arsenic speciation analysis to assess exposures. In these analyses, part-per-billion sensitivity was achieved with a mean precision of less than 12% coefficient of variation, and with excellent interlaboratory comparability.

Flow potentiometric and constant-current stripping analysis for arsenic(V) without prior chemical reduction to arsenic(III): Application to the Determination of Total Arsenic in Seawater and Urine

Arsenic(V) is reduced to elemental arsenic on a gold-coated platinum-fibre electrode at electrolysis potentials below −1.60 V vs. Ag/AgCl and subsequently re-oxidized, either by means of a constant current, or chemically, with gold(III) as oxidant. Total arsenic in acidified seawater can be determined by means of electrolysis for 60 s at −1.80 V vs. Ag/AgCl and subsequent stripping in 4 M hydrochloric acid containing 2.5 M calcium chloride. The detection limit obtained after 60 s of electrolysis (ca. 0.1 μg1 −1) is about ten times lower than that obtained by the electrochemical stripping methods for arsenic(III) reported hitherto. Total arsenic in urine is determined after digestion with nitric acid and hydrogen peroxide.

Urinary arsenic speciation by high-performance liquid chromatography/atomic absorption spectrometry for monitoring occupational exposure to inorganic arsenic

Total urinary arsenic determinations are often used to assess occupational exposure to inorganic arsenic. Ingestion of sea food can increase the normal background levels of total arsenic in urine by up to an order of magnitude, but this arsenic has relatively little toxicity; it is tightly bound as arsenobetaine. The excretion of inorganic arsenic and its metabolites dimethylarsenic acid (DMA) and monomethylarsonic acid (MMA) is not influenced by the consumption of arsenic from sea food. Specific measurements of DMA, MMA and inorganic arsenic provide a more reliable indicator or exposure than total urinary arsenic levels. An automated atomic absorption method involving high-performance liquid chromatographic separation of the arsenic species and continuous hydride generation is described for the determination of arsenite, arsenate, DMA and MMA at μg As l −1 levels. The method is used to study normal urinary arsenic levels in laboratory staff and arsenic excretion by exposed workers.

A rapid method for the selective analysis of total urinary metabolites of inorganic arsenic.

Total urinary arsenic has traditionally been used for assessing occupational exposure to inorganic arsenic. However, dietary arsenic, especially from seafood, may greatly influence this value. This paper describes a fast and convenient method for routinely measuring the combined amount of inorganic arsenic, methylarsonic acid, and dimethylarsinic acid, which are the major urinary metabolites after exposure to inorganic arsenic. Organic arsenic compounds of marine origin are not biotransformed to inorganic arsenic or methylated arsenic acids to any significance in the human body. They do not produce arsines when treated with the reducing agent in the proposed method and will therefore not interfere with the measurements. The sensitivity, accuracy, and precision of the proposed method are sufficient for the determination of concentrations of arsenic normally found in the urine of nonexposed persons. The method is based on a commercially available hydride generation kit attached to an atomic absorption spectrophotometer.